deltatrials
Terminated EARLY_PHASE1 INTERVENTIONAL 1-arm NCT01466855

A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma (IARB1)

A Pilot Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma

Sponsor: Children's Hospital Medical Center, Cincinnati

Conditions Retinoblastoma
Interventions Intra-Ophthalmic Artery Topotecan Infusion
Updated 7 times since 2017 Last updated: Sep 10, 2020 Started: Oct 31, 2011 Primary completion: Oct 31, 2015 Completion: Oct 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Competing studies

Other terminated trials from Children's Hospital Medical Center, Cincinnati

See all terminations from Children's Hospital Medical Center, Cincinnati

Other Retinoblastoma trials with similar outcome

Browse all Retinoblastoma trials

Listed as NCT01466855, this EARLY_PHASE1 trial focuses on Retinoblastoma and remains terminated or withdrawn. Sponsored by Children's Hospital Medical Center, Cincinnati, it has been updated 7 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Oct 2020 · 28 months · monthly snapshotTerminated~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated EARLY_PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated EARLY_PHASE1

  4. Oct 2020 — Jan 2021 [monthly]

    Terminated EARLY_PHASE1

    Phase: NA → EARLY_PHASE1

  5. Jun 2018 — Oct 2020 [monthly]

    Terminated NA

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Terminated NA

  2. Jan 2017 — Feb 2017 [monthly]

    Terminated NA

    First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Children's Hospital Medical Center, Cincinnati
Data source: Children's Hospital Medical Center, Cincinnati

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations